Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer.
Liao J, Lai H, Liu C, Zhang X, Ou Q, Li Q, Li Y, Wang Z, Liu C, Wu X, Wang H, Yu H, Sun S, Zhao X, Hu Z, Zhang Y, Lin Y, Yu B, Huang S, Wang J.
Liao J, et al. Among authors: liu c.
Cancer Sci. 2023 Jul;114(7):2774-2786. doi: 10.1111/cas.15804. Epub 2023 Apr 20.
Cancer Sci. 2023.
PMID: 37014183
Free PMC article.